임상 한눈에 보기

• 84건의 ClinicalTrials.gov 임상 기록
• Phase·Status 요약은 enrollment 상위 표본 기준입니다
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 2 · Phase 2, Phase 3 · Phase 1, Phase 2
• Status: Approved for marketing · Completed · Recruiting
• 주요 endpoint: Factors associated with an increased rate of fatality among reports with an immune-related adverse event (irAE). · Factors associated with an increased reporting of main irAE types · Time to onset for each irAE type · Rate of relapse with treatment rechallenge · Determine whether adding experimental agents to standard neoadjuvant medications increases the probability of pathologic complete response (pCR) over standard neoadjuvant chemotherapy for each biomarker signature established at trial entry.
• 등록된 결과: ORR 44%
• 핵심: The goal of this study is to learn if giving cemiplimab and vidutolimod together could be effective in treating advanced…

임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.